← All Sponsors
SPONSOR

Talengen Institute of Life Sciences, Shenzhen, P.R. China.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Critical Limb Ischemia
NCT06482892 Phase 2
Recruiting

TP03HN106 in Patients With Critical Limb Ischemia

Critical Limb Ischemia
China View Trial →